Drawing for OPTINOSE

USPTO serial 98683086

OPTINOSE

Reviewed by CopyMark Law Group

Status 731Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
MASTEE, BRIAN JAMES
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 731: Status 731 means the second six-month extension to file a Statement of Use was granted. File a Statement of Use or the next extension before the deadline expires.

Need help with OPTINOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $349*

Plus Government fees of $300

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachelle A. Dubow

Rachelle A. Dubow Morgan, Lewis & Bockius LLPOne Federal StreetBoston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treatment of nasal conditions; pharmaceutical preparations for treating chronic rhinosinusitis, and nasal polyps; pharmaceutical preparations for treating nose disorders; devices for nasal delivery of drug substances, sold filled with pharmaceutical preparations for treating nasal conditions, chronic rhinosinusitis, nasal polyps, and nose disorders; liquid delivery devices for nasal delivery of drug substances in liquid form, sold filled with pharmaceutical preparations for treating nasal conditions, chronic rhinosinusitis, nasal polyps, and nose disorders; spray pump devices for nasal delivery of drug substances, sold filled with pharmaceutical preparations for treating nasal conditions, chronic rhinosinusitis, nasal polyps, and nose disorders; intranasal drug delivery devices, sold filled with pharmaceutical preparations for treating nasal conditions, chronic rhinosinusitis, nasal polyps, and nose disorders; replacement parts and structural parts for all of the aforementioned delivery devicesACTIVE—
010Devices for nasal delivery of drug substances, sold empty; liquid delivery devices for nasal delivery of drug substances in liquid form, sold empty; spray pump devices for nasal delivery of drug substances, sold empty; intranasal drug delivery devices, sold empty; replacement parts and structural parts for all of the aforementioned goodsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 26, 2026EX2GSOU EXTENSION 2 GRANTED—
Aug 26, 2026EXT2SOU EXTENSION 2 FILED—
Aug 26, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2026ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Feb 18, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 17, 2026EX1GSOU EXTENSION 1 GRANTED—
Feb 17, 2026EXT1SOU EXTENSION 1 FILED—
Feb 17, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 26, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 1, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 1, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 28, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 27, 2025XAECEXAMINER'S AMENDMENT ENTERED—
May 27, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 27, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
May 27, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 3, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 22, 2025DOCKASSIGNED TO EXAMINER—
Feb 21, 2025MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Feb 21, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 5, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance